Monitoring therapeutic monoclonal antibodies in brain tumor

Bevacizumab induces normalization of abnormal blood vessels, making them less leaky. By binding to vascular endothelial growth factor, it indirectly attacks the vascular tumor mass. The optimal delivery of targeted therapies including monoclonal antibodies or anti-angiogenesis drugs to the target ti...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:MAbs
Huvudupphovsmän: Ait-Belkacem, Rima, Berenguer, Caroline, Villard, Claude, Ouafik, L’Houcine, Figarella-Branger, Dominique, Beck, Alain, Chinot, Olivier, Lafitte, Daniel
Materialtyp: Artigo
Språk:Inglês
Publicerad: Taylor & Francis 2014
Ämnen:
Short Communication
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622724/
https://ncbi.nlm.nih.gov/pubmed/25484065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.34405
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk